Yechezkely Hayon Daniella 4
4 · QTREX Quantum Ltd. · Filed Jul 14, 2026
Research Summary
AI-generated summary of this filing
QTREX (QTEX) CTO Yechezkely Hayon Receives 550,000 RSU Award
What Happened
- Yechezkely Hayon Daniella, Chief Technology Officer of Qtrex Quantum Ltd. (QTEX), received an award of 550,000 restricted share units (RSUs) on July 6, 2026. The Form 4 lists the acquisition code as "A" and reports $0 cash paid for the award (grant recorded at $0 per share).
Key Details
- Transaction date: 2026-07-06; Form filed: 2026-07-14 (filed after the transaction date).
- Price: $0.00 per RSU (award/grant — no cash paid).
- Shares acquired: 550,000 RSUs.
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs granted under Qtrex Quantum Ltd.’s 2019 Plan. Vesting: 183,334 RSUs vest on July 1, 2027; remaining RSUs vest quarterly over the following two years (per footnote F1).
- Filing timeliness: The report was filed 8 days after the transaction date; Form 4s are generally due within two business days, so this appears to be a late filing.
Context
- RSUs are a compensation award that convert to shares only as they vest; this grant does not represent an open-market purchase or sale and does not mean shares were immediately sold. Such awards are common executive compensation and should be viewed as part of pay/retention rather than a direct market sentiment signal.
Insider Transaction Report
Form 4
Yechezkely Hayon Daniella
Chief Technology Officer
Transactions
- Award
Ordinary Shares
[F1]2026-07-06+550,000→ 1,330,000 total
Footnotes (1)
- [F1]The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event.
Signature
/s/ Daniella Yechezkely Hayon|2026-07-14